INVESTIGATION OF THE ASSOCIATION BETWEEN SERUM C-REACTIVE PROTEIN DYNAMICS AND THE DEVELOPMENT OF SEPTIC SHOCK AND THE REQUIREMENT FOR INVASIVE MECHANICAL VENTILATION IN HOSPITALIZED PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA
Main Article Content
Abstract
Objective: To investigate the prognostic significance of the relative change in serum C-reactive protein (CRP) between day 1 and day 3 for predicting the development of septic shock and the requirement for invasive mechanical ventilation (IMV) in hospitalized patients with community-acquired pneumonia (CAP), and to determine the optimal cut off values of ΔCRP % for these adverse outcomes.
Materials and methods: A prospective observational cohort study was conducted on 128 adult inpatients (≥18 years) with CAP admitted to Cho Ray Hospital from October 2024 to March 2025. Serum CRP concentrations were quantified on days 1 and 3 using a latex-enhanced immunoturbidimetric assay.
Results: Among 128 patients, 71.1 % were aged over 65 years. The incidence of septic shock was 18.0 %, and 21.2 % required IMV. The early CRP dynamics (ΔCRP%) between day 1 and day 3 were significantly associated with both complications. An increase in CRP >16.8% from day 1 to day 3 predicted the development of septic shock (AUC = 0.90, sensitivity 78.3%, specificity 90.5%), whereas a decrease in CRP <41.1% from day 1 to day 3 predicted the requirement for invasive mechanical ventilation (AUC = 0.78, sensitivity 92.9%, specificity 54.0%). Conclusion: Early CRP dynamics (ΔCRP%) between day 1 and day 3 were identified as an independent prognostic marker for the development of septic shock and the requirement for invasive mechanical ventilation in hospitalized patients with community-acquired pneumonia. Among these outcomes, CRP kinetics demonstrated outstanding prognostic accuracy in predicting septic shock.
Keywords
Community-acquired pneumonia, C-reactive protein, ΔCRP% (CRP dynamics), prognostic marker for septic shock, requirement for invasive mechanical ventilation
Article Details
References
2. National Institute for Health and Care Excellence (NICE), Pneumonia: diagnosis and management (NG250). NICE Guideline, 2025.
3. Dinh, A., et al., Community-acquired pneumonia: 2025 French guidelines. Respir Med Res, 2025. 101161.
4. Saldías Peñafiel, F., et al., Utilidad de la proteína C reactiva sérica en el diagnóstico y tratamiento del adulto inmunocompetente hospitalizado por neumonía adquirida en la comunidad. Rev Med Chile, 2019. 147: p. 983–992.
5. Huang, S., et al., Relationships between human serum albumin levels and septic shock, in-hospital, and out-of-hospital mortality in elderly patients with pneumonia in different BMI ranges. Pneumonia, 2024. 16:17.
6. Sellarès-Nadal, J., et al., Community-acquired pneumonia in hospitalised patients: changes in aetiology, clinical presentation, and severity outcomes in a 10-year period. Ann Med, 2022. 54(1): p. 3052–3059.
7. Meslé, V., et al., Unexpected discovery of CRP analytical interference: A case report. Clin Biochem, 2024. 130: p. 110781.